Boye, Kristina S. http://orcid.org/0000-0002-5953-5929
Sapin, Hélène http://orcid.org/0000-0003-2602-8450
Dong, Wenxiu
Williamson, Suzanne http://orcid.org/0009-0005-2461-1919
Lee, Clare J. http://orcid.org/0000-0002-0824-0207
Thieu, Vivian Thuyanh
Clinical trials referenced in this document:
Documents that mention this clinical trial
Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
https://doi.org/10.1007/s13300-023-01457-7
Documents that mention this clinical trial
Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
https://doi.org/10.1007/s13300-023-01457-7
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3
https://doi.org/10.1007/s13300-023-01398-1
Documents that mention this clinical trial
Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
https://doi.org/10.1007/s13300-023-01457-7
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3
https://doi.org/10.1007/s13300-023-01398-1
Documents that mention this clinical trial
Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
https://doi.org/10.1007/s13300-023-01457-7
Documents that mention this clinical trial
Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide
https://doi.org/10.1007/s13300-023-01457-7
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 20 June 2023
Accepted: 27 July 2023
First Online: 5 September 2023
Declarations
:
: Kristina S Boye, Hélène Sapin, Clare J. Lee and Vivian Thuyanh Thieu are full-time employees and minor stockholders of Eli Lilly and Company. Wenxiu Dong and Suzanne Williamson work as consultants for Eli Lilly and Company.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Study protocols were approved by local ethical review boards, and all participants provided written informed consent. All studies were conducted in accordance with the Declaration of Helsinki and Good Clinical Practice.